News
Oral semaglutide demonstrated superior cardiometabolic outcomes relative to placebo and active comparators, including empaglifozin, in T2D.
What happens to your body after you stop taking Ozempic has been revealed, after the use of weight loss medications has ...
Russian public procurements of drugs based on the active ingredient semaglutide, which is an original drug from Denmark’s ...
That is why the current wave of fake Ozempic-style drugs now circulating in the U.S by unlicensed and often foreign companies ...
Two years on from The Royal Gazette’s first report on a new wave of diabetes drugs with broader health benefits, the island’s ...
View original content to download multimedia ... modality-membership-driven-solution-for-body-contouring-in-the-post-semaglutide-era-302434677.html We sell different types of products and services ...
SIGNIFICANT EVENTS DURING 1 JANUARY - 31 MARCH 2025Iconovo and Lonza have entered a collaboration to develop spray-dried formulations of an intranasal biologic drug for Iconovo's proprietary intranasa ...
Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for cardiometabolic diseases and GI oncological indications announced today that it ...
Many Americans are taking GLP1 medications, which include weight loss and diabetes medications Ozempic and Wegovy.
Researchers estimated that nearly 25,000 ED visits were related to semaglutide adverse events. They were surprised to learn that 16% involved hypoglycemia. An estimated 24,499 people visited the ...
A US judge has rejected efforts by a compounded drugs industry group to keep making an alternative version of Novo Nordisk’s popular drug semaglutide, opening the door for the US Food and Drug ...
Ozempic face: The unexpected side effect of using the popular weight loss drug (and how to avoid it)
Ozempic, a popular drug for type 2 diabetes, has gained traction for its weight loss benefits, but it comes with potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results